Skip to content

CymaBay Therapeutics, Inc.: filings

Every CymaBay Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 42 filings, each linked to its SEC index.

Filing record ends 2024-02-28

The latest filing in this captured record is a 10-K filed 2024-02-28. No later filing is in the SEC companyfacts record captured on 2026-09-22. CymaBay Therapeutics, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-K2024-02-28fiscal FY 2023431110001193125-24-050758
10-Q2023-11-07fiscal Q3 2023381140001193125-23-272401
10-Q2023-08-10fiscal Q2 2023381100001193125-23-209009
10-Q2023-05-15fiscal Q1 202337760001193125-23-144944
10-K2023-03-23fiscal FY 202241820001193125-23-077859
10-Q2022-11-14fiscal Q3 2022351040001193125-22-284669
10-Q2022-08-11fiscal Q2 2022361000001193125-22-218509
10-Q2022-05-12fiscal Q1 202233680001193125-22-148621
10-K2022-03-17fiscal FY 202137740001193125-22-078287
10-Q2021-11-10fiscal Q3 202133980001193125-21-325946
10-Q2021-08-12fiscal Q2 202131860001193125-21-244646
10-Q2021-05-13fiscal Q1 202131640001193125-21-160469
10-K2021-03-25fiscal FY 202037750001193125-21-094424
10-Q2020-11-05fiscal Q3 202034960001193125-20-286811
10-Q2020-08-10fiscal Q2 2020371030001193125-20-214900
10-Q2020-05-11fiscal Q1 202037720001193125-20-139038
10-K2020-03-16fiscal FY 201944820001193125-20-074946
10-Q2019-11-05fiscal Q3 2019421140001564590-19-040357
10-Q2019-08-07fiscal Q2 2019421090001564590-19-030039
10-Q2019-05-08fiscal Q1 201942770001564590-19-017174
10-K2019-02-28fiscal FY 2018431440001564590-19-005435
10-Q2018-11-06fiscal Q3 2018381030001564590-18-027388
10-Q2018-08-09fiscal Q2 2018371000001564590-18-021029
10-Q2018-05-08fiscal Q1 201833650001564590-18-011853
10-K2018-03-15fiscal FY 201739770001564590-18-005831
10-Q2017-11-08fiscal Q3 201732930001193125-17-337226
10-Q2017-08-10fiscal Q2 201732930001193125-17-254432
10-Q2017-05-11fiscal Q1 201731640001193125-17-167267
10-K2017-03-23fiscal FY 201637740001193125-17-093759
10-Q2016-11-09fiscal Q3 201632930001193125-16-764311
10-Q2016-08-09fiscal Q2 201632930001193125-16-676729
10-Q2016-05-11fiscal Q1 201632660001193125-16-587089
10-K2016-03-29fiscal FY 201538750001193125-16-521392
10-Q2015-11-12fiscal Q3 201535980001193125-15-375650
10-Q2015-08-11fiscal Q2 201535990001193125-15-285792
10-Q2015-05-11fiscal Q1 201535700001193125-15-182047
10-K2015-03-23fiscal FY 201437750001193125-15-101933
10-Q2014-11-14fiscal Q3 201436980001193125-14-413218
10-Q2014-08-14fiscal Q2 201436970001193125-14-310376
10-Q2014-05-15fiscal Q1 201434670001193125-14-201070
10-K2014-03-31fiscal FY 201338770001193125-14-124127
10-Q/A2013-12-16fiscal Q3 201335970001193125-13-474751

Inspect the source

Entity
CymaBay Therapeutics, Inc. / CIK 0001042074
Captured
SEC response SHA-256
fcec8ca401aaf0e5fff2f644eb2ac8431d2a25ee205f4a00164314124bd806de

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001042074.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))